Irbesartan Market Report

Global and Region Irbesartan Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：220
  • REPORT CODE：GMM962758
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Irbesartan market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Irbesartanmarket, defines the market attractiveness level of Irbesartan market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Irbesartan industry, describes the types of Irbesartan market, the applications of major players and the market size, and deeply analyzes the current situation of the global Irbesartan market and the development prospects and opportunities of Irbesartan industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Irbesartan market in Chapter 13.

    By Player:

    • Apotex

    • Sumitomo Dainippon Pharma

    • Taj Pharmaceuticals

    • Angita Pharma

    • Auro Pharma

    • Avanstra

    • Shionogi

    • Verdant Life Sciences

    • Tianjin Huairen Pharmaceutical

    • Yuanhe Pharmaceutical

    • Xiansheng Pharmaceutical

    • Jiangsu Hengrui Medicine

    • Novartis

    • Zhejiang Huahai Pharmaceutical

    • Hanall

    • Sanofi

    • Jiangsu Wangao Pharmaceutical

    • Zhuhai Rundu Pharma

    • BMS

    • Teva

    • Zhejiang Ainuo Pharmaceutical

    • CTTQ

    By Type:

    • Combination Drugs

    • Prescribed Drugs

    By End-User:

    • Hyperlipidemia

    • High Blood Pressure

    • Heart Failure

    • Kidney Disease

    • Fibrous Fibrillation

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Irbesartan Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Irbesartan Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Irbesartan Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Irbesartan Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Irbesartan Market Analysis and Outlook to 2022

    • 7.1 Global Irbesartan Consumption (2017-2022)

    • 7.2 United States Irbesartan Consumption (2017-2022)

    • 7.3 Europe Irbesartan Consumption (2017-2022)

    • 7.4 China Irbesartan Consumption (2017-2022)

    • 7.5 Japan Irbesartan Consumption (2017-2022)

    • 7.6 India Irbesartan Consumption (2017-2022)

    • 7.7 South Korea Irbesartan Consumption (2017-2022)

    8 Region and Country-wise Irbesartan Market Analysis and Outlook to 2028

    • 8.1 Global Irbesartan Consumption Forecast (2022-2028)

    • 8.2 United States Irbesartan Consumption Forecast (2022-2028)

    • 8.3 Europe Irbesartan Consumption Forecast (2022-2028)

    • 8.4 China Irbesartan Consumption Forecast (2022-2028)

    • 8.5 Japan Irbesartan Consumption Forecast (2022-2028)

    • 8.6 India Irbesartan Consumption Forecast (2022-2028)

    • 8.7 South Korea Irbesartan Consumption Forecast (2022-2028)

    9 Global Irbesartan Market Outlook by Types and Applications to 2022

    • 9.1 Global Irbesartan Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Combination Drugs Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Prescribed Drugs Consumption and Growth Rate (2017-2022)

    • 9.2 Global Irbesartan Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hyperlipidemia Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global High Blood Pressure Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Heart Failure Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Kidney Disease Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Fibrous Fibrillation Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Irbesartan Market Outlook by Types and Applications to 2028

    • 10.1 Global Irbesartan Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Combination Drugs Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Prescribed Drugs Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Irbesartan Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hyperlipidemia Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global High Blood Pressure Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Heart Failure Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Kidney Disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Fibrous Fibrillation Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.6 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Irbesartan Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Irbesartan Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Irbesartan Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Irbesartan Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Irbesartan Market Competitive Analysis

    • 14.1 Apotex

      • 14.1.1 Apotex Company Details

      • 14.1.2 Apotex Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Apotex Irbesartan Product and Service

    • 14.2 Sumitomo Dainippon Pharma

      • 14.2.1 Sumitomo Dainippon Pharma Company Details

      • 14.2.2 Sumitomo Dainippon Pharma Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Sumitomo Dainippon Pharma Irbesartan Product and Service

    • 14.3 Taj Pharmaceuticals

      • 14.3.1 Taj Pharmaceuticals Company Details

      • 14.3.2 Taj Pharmaceuticals Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Taj Pharmaceuticals Irbesartan Product and Service

    • 14.4 Angita Pharma

      • 14.4.1 Angita Pharma Company Details

      • 14.4.2 Angita Pharma Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Angita Pharma Irbesartan Product and Service

    • 14.5 Auro Pharma

      • 14.5.1 Auro Pharma Company Details

      • 14.5.2 Auro Pharma Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Auro Pharma Irbesartan Product and Service

    • 14.6 Avanstra

      • 14.6.1 Avanstra Company Details

      • 14.6.2 Avanstra Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Avanstra Irbesartan Product and Service

    • 14.7 Shionogi

      • 14.7.1 Shionogi Company Details

      • 14.7.2 Shionogi Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Shionogi Irbesartan Product and Service

    • 14.8 Verdant Life Sciences

      • 14.8.1 Verdant Life Sciences Company Details

      • 14.8.2 Verdant Life Sciences Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Verdant Life Sciences Irbesartan Product and Service

    • 14.9 Tianjin Huairen Pharmaceutical

      • 14.9.1 Tianjin Huairen Pharmaceutical Company Details

      • 14.9.2 Tianjin Huairen Pharmaceutical Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Tianjin Huairen Pharmaceutical Irbesartan Product and Service

    • 14.10 Yuanhe Pharmaceutical

      • 14.10.1 Yuanhe Pharmaceutical Company Details

      • 14.10.2 Yuanhe Pharmaceutical Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Yuanhe Pharmaceutical Irbesartan Product and Service

    • 14.11 Xiansheng Pharmaceutical

      • 14.11.1 Xiansheng Pharmaceutical Company Details

      • 14.11.2 Xiansheng Pharmaceutical Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Xiansheng Pharmaceutical Irbesartan Product and Service

    • 14.12 Jiangsu Hengrui Medicine

      • 14.12.1 Jiangsu Hengrui Medicine Company Details

      • 14.12.2 Jiangsu Hengrui Medicine Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Jiangsu Hengrui Medicine Irbesartan Product and Service

    • 14.13 Novartis

      • 14.13.1 Novartis Company Details

      • 14.13.2 Novartis Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Novartis Irbesartan Product and Service

    • 14.14 Zhejiang Huahai Pharmaceutical

      • 14.14.1 Zhejiang Huahai Pharmaceutical Company Details

      • 14.14.2 Zhejiang Huahai Pharmaceutical Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Zhejiang Huahai Pharmaceutical Irbesartan Product and Service

    • 14.15 Hanall

      • 14.15.1 Hanall Company Details

      • 14.15.2 Hanall Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Hanall Irbesartan Product and Service

    • 14.16 Sanofi

      • 14.16.1 Sanofi Company Details

      • 14.16.2 Sanofi Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Sanofi Irbesartan Product and Service

    • 14.17 Jiangsu Wangao Pharmaceutical

      • 14.17.1 Jiangsu Wangao Pharmaceutical Company Details

      • 14.17.2 Jiangsu Wangao Pharmaceutical Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Jiangsu Wangao Pharmaceutical Irbesartan Product and Service

    • 14.18 Zhuhai Rundu Pharma

      • 14.18.1 Zhuhai Rundu Pharma Company Details

      • 14.18.2 Zhuhai Rundu Pharma Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Zhuhai Rundu Pharma Irbesartan Product and Service

    • 14.19 BMS

      • 14.19.1 BMS Company Details

      • 14.19.2 BMS Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 BMS Irbesartan Product and Service

    • 14.20 Teva

      • 14.20.1 Teva Company Details

      • 14.20.2 Teva Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

      • 14.20.3 Teva Irbesartan Product and Service

    • 14.21 Zhejiang Ainuo Pharmaceutical

      • 14.21.1 Zhejiang Ainuo Pharmaceutical Company Details

      • 14.21.2 Zhejiang Ainuo Pharmaceutical Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

      • 14.21.3 Zhejiang Ainuo Pharmaceutical Irbesartan Product and Service

    • 14.22 CTTQ

      • 14.22.1 CTTQ Company Details

      • 14.22.2 CTTQ Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

      • 14.22.3 CTTQ Irbesartan Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Irbesartan

    • Figure Irbesartan Picture

    • Table Global Irbesartan Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Irbesartan Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Irbesartan Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Irbesartan Consumption by Country (2017-2022)

    • Figure United States Irbesartan Consumption and Growth Rate (2017-2022)

    • Table Europe Irbesartan Consumption and Growth Rate (2017-2022)

    • Figure China Irbesartan Consumption and Growth Rate (2017-2022)

    • Figure Japan Irbesartan Consumption and Growth Rate (2017-2022)

    • Figure India Irbesartan Consumption and Growth Rate (2017-2022)

    • Figure South Korea Irbesartan Consumption and Growth Rate (2017-2022)

    • Figure Global Irbesartan Consumption Forecast by Country (2022-2028)

    • Figure United States Irbesartan Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Irbesartan Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Irbesartan Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Irbesartan Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Irbesartan Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Irbesartan Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Combination Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Prescribed Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Hyperlipidemia Consumption and Growth Rate (2017-2022)

    • Figure Global High Blood Pressure Consumption and Growth Rate (2017-2022)

    • Figure Global Heart Failure Consumption and Growth Rate (2017-2022)

    • Figure Global Kidney Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Fibrous Fibrillation Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Combination Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Prescribed Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hyperlipidemia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global High Blood Pressure Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Heart Failure Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Kidney Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Fibrous Fibrillation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Irbesartan Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Irbesartan Export by Region (Top 5 Countries) (2017-2028)

    • Table Apotex (Foundation Year, Company Profile and etc.)

    • Table Apotex Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

    • Table Apotex Irbesartan Product and Service

    • Table Sumitomo Dainippon Pharma (Foundation Year, Company Profile and etc.)

    • Table Sumitomo Dainippon Pharma Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sumitomo Dainippon Pharma Irbesartan Product and Service

    • Table Taj Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Taj Pharmaceuticals Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

    • Table Taj Pharmaceuticals Irbesartan Product and Service

    • Table Angita Pharma (Foundation Year, Company Profile and etc.)

    • Table Angita Pharma Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

    • Table Angita Pharma Irbesartan Product and Service

    • Table Auro Pharma (Foundation Year, Company Profile and etc.)

    • Table Auro Pharma Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

    • Table Auro Pharma Irbesartan Product and Service

    • Table Avanstra (Foundation Year, Company Profile and etc.)

    • Table Avanstra Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

    • Table Avanstra Irbesartan Product and Service

    • Table Shionogi (Foundation Year, Company Profile and etc.)

    • Table Shionogi Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shionogi Irbesartan Product and Service

    • Table Verdant Life Sciences (Foundation Year, Company Profile and etc.)

    • Table Verdant Life Sciences Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

    • Table Verdant Life Sciences Irbesartan Product and Service

    • Table Tianjin Huairen Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Tianjin Huairen Pharmaceutical Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tianjin Huairen Pharmaceutical Irbesartan Product and Service

    • Table Yuanhe Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Yuanhe Pharmaceutical Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

    • Table Yuanhe Pharmaceutical Irbesartan Product and Service

    • Table Xiansheng Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Xiansheng Pharmaceutical Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

    • Table Xiansheng Pharmaceutical Irbesartan Product and Service

    • Table Jiangsu Hengrui Medicine (Foundation Year, Company Profile and etc.)

    • Table Jiangsu Hengrui Medicine Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jiangsu Hengrui Medicine Irbesartan Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Irbesartan Product and Service

    • Table Zhejiang Huahai Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Zhejiang Huahai Pharmaceutical Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

    • Table Zhejiang Huahai Pharmaceutical Irbesartan Product and Service

    • Table Hanall (Foundation Year, Company Profile and etc.)

    • Table Hanall Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hanall Irbesartan Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Irbesartan Product and Service

    • Table Jiangsu Wangao Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Jiangsu Wangao Pharmaceutical Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jiangsu Wangao Pharmaceutical Irbesartan Product and Service

    • Table Zhuhai Rundu Pharma (Foundation Year, Company Profile and etc.)

    • Table Zhuhai Rundu Pharma Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

    • Table Zhuhai Rundu Pharma Irbesartan Product and Service

    • Table BMS (Foundation Year, Company Profile and etc.)

    • Table BMS Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

    • Table BMS Irbesartan Product and Service

    • Table Teva (Foundation Year, Company Profile and etc.)

    • Table Teva Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Irbesartan Product and Service

    • Table Zhejiang Ainuo Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Zhejiang Ainuo Pharmaceutical Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

    • Table Zhejiang Ainuo Pharmaceutical Irbesartan Product and Service

    • Table CTTQ (Foundation Year, Company Profile and etc.)

    • Table CTTQ Irbesartan Sales, Price, Value and Gross Profit (2017-2022)

    • Table CTTQ Irbesartan Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US